… genital warts before vaccination, we applied 6- and 12-month buffer periods from last and
first vaccine … and 162 among 3-dose vaccinees; vaccine effectiveness was 68% and 76% for …

… of genital warts (GW) after infection, monitoring GW trends may provide early evidence of
population-level human papillomavirus (HPV) vaccine effectiveness. … HPV vaccine may be …

… quadrivalent HPV vaccine were effective against genital warts in our population. Moreover,
with low vaccine coverage the incidence of genital warts decreased only in the vaccinated. …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts (GW)
in women aged 14–23 years and to estimate the incidence of GW in the whole population …

… The outcomes are inconsistent: the FUTURE II Study Group found the quadrivalent HPV
vaccine is effective in preventing AGWs related to HPV-6, -11, -16, and -18 in women who were …

… -level vaccination histories and compared reductions in risks of warts between vaccinated
and … Estimates of trends in anogenital warts or vaccine effectiveness against anogenital warts …

… In this systematic review we found that the quadrivalent HPV vaccine is effective in preventing
… Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a …

… In this review, we present data for the direct impact/effectiveness in vaccinated cohorts. We
also present data for the indirect impact, or herd protection, in the unvaccinated population, …

… for the benefits of HPV vaccination and offer HPV vaccines. Additionally, our results
demonstrating strong evidence of quadrivalent HPV vaccine effectiveness can help the governments …

… Perhaps the most effective means for managing HPV disease would be a vaccine that
prevents the occurrence of genital warts. Although it is unlikely that such a vaccine will be …